vTv Therapeutics (FRA:5VT0) Total Current Assets: €85.47 Mil (As of Mar. 2026)

What is vTv Therapeutics Total Current Assets?

vTv Therapeutics FRA:5VT0 +3.21% 35 Total Current Assets is €85.47 Mil as of Mar. 2026. GuruFocus rates FRA:5VT0 with a GF Score™ of 35/100 and a GF Value™ of €7,190.85.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. vTv Therapeutics's total current assets for the quarter that ended in Mar. 2026 was €85.47 Mil.

vTv Therapeutics (FRA:5VT0) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

vTv Therapeutics's Liquidation Value for the quarter that ended in Mar. 2026 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	84.844	-	7.659	+	0.75 * 0	+	0.5 * 0
=	77.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

vTv Therapeutics Total Current Assets Related Terms

vTv Therapeutics Total Current Assets Historical Data

* Premium members only.

The historical data trend for vTv Therapeutics's Total Current Assets can be seen below:

vTv Therapeutics Total Current Assets Chart

vTv Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Current Assets

Get a 7-Day Free Trial

13.83

25.58

9.77

36.40

76.77

vTv Therapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Current Assets	Get a 7-Day Free Trial															29.52	22.87	84.74	76.77	85.47

35GF Score

vTv Therapeutics Inc FRA:5VT0

Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

vTv Therapeutics Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

vTv Therapeutics's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	75.948	+	0	+	0	+	0.82100000000001
	=	76.77

vTv Therapeutics's Total Current Assets for the quarter that ended in Mar. 2026 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	84.844	+	0	+	0	+	0.625
	=	85.47

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →

What does a Total Current Assets of €85.47 Mil mean?

vTv Therapeutics (FRA:5VT0) has a Total Current Assets of €85.47 Mil as of Mar. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for vTv Therapeutics and its competitors.

Is vTv Therapeutics' Total Current Assets too high?

vTv Therapeutics' current Total Current Assets is €85.47 Mil. Overall, vTv Therapeutics has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.

How does vTv Therapeutics' Total Current Assets compare to SMNR and CNTB?

vTv Therapeutics' Total Current Assets of €85.47 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Current Assets for a Biotechnology company?

A good Total Current Assets depends on the Biotechnology industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Current Assets mean?

A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for vTv Therapeutics and its competitors. vTv Therapeutics's current Total Current Assets is €85.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is vTv Therapeutics stock overvalued right now?

vTv Therapeutics (FRA:5VT0) has a current Total Current Assets of €85.47 Mil. The stock's GF Value™ is €7,190.85, compared to a current price of €32.20 — trading 99.6% below its estimated fair value. The current Total Current Assets is €85.47 Mil. vTv Therapeutics' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Current Assets calculated?

Total Current Assets is calculated from a company's financial statements. For vTv Therapeutics (FRA:5VT0), the current Total Current Assets is €85.47 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is vTv Therapeutics (FRA:5VT0) Overvalued in 2026?

Based on GuruFocus' analysis, vTv Therapeutics stock appears to be undervalued. The current stock price of €32.20 is trading 99.6% below its estimated GF Value™ of €7,190.85.

Key valuation signals for FRA:5VT0:

Total Current Assets: €85.47 Mil
GF Value™: €7,190.85 vs. price of €32.20 (99.6% below fair value)
GF Score™: 35/100

No single metric tells the full story. See the FRA:5VT0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

vTv Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies SMNR CNTB ENLV MENS SPRO VXRT ACOG HURA ADCT GNLX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges VTVT:USA

Address 3980 Premier Drive, Suite 110, High Point, NC, USA, 27265

Website https://www.vtvtherapeutics.com

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

35GF Score

Get the complete analysis for FRA:5VT0

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€32.20

Price

€7,190.85

GF Value

View FRA:5VT0 Analysis

See Total Current Assets data for all stocks →